Clinical Trial Update: To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 1/2 study of INCB000928 in myelodysplastic syndromes and multiple myeloma, with results posted eva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• INCB000928

Snippet

Sponsor: Incyte Corporation | Conditions: Myelodysplastic Syndromes, Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-10-22